Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Reported Financial Results For 3Q2015, Cut Down Work Force By 60%

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) announced financial results for the recently concluded 3Q2015. As per the reports, the biggest highlight was its announcement to fire almost 60% of its full-time employees due to revenue pressure. Insights of The Matter Going forward, not more than 33 full-time employees will work for Synta Pharmaceuticals. As a result of […]

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Shows Promise With Anti-Cancer Drug

Boston, MA 10/29/2013 (wallstreetpr) – Shares of Synta Pharmaceuticals Corp. (NASDAQ:SNTA) plummeted to as low as $5.10 hours after the USA-based drug manufacturer presented positive one-year follow-up results from its GALAXY-1 trial of its ambitious anti-cancer innovation Ganetespib at the 15th World Conference on Lung Cancer (WCLC) in Sydney, Australia. GALAXY-1 is Synta Pharmaceutical’s (Synta) ambitious global, […]

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Shares Up by 5%

Boston, MA 10/11/2013 (wallstreetpr) – Synta Pharmaceuticals Corp. (NASDAQ:SNTA) share price shot up by close to 5% during single day of trading on October 10. It was trading at $6.43 per share on October 10 close of business as against a previous day close of $6.12. While the valuation went up the stock did not see […]